Patient Access Network offers assistance for patients with uveitis
Washington, D.C. October 20, 2010. –Patient Access Network (PAN) Foundation has begun providing co-payment assistance for medications to underinsured patients with uveitis. Qualified patients will be granted up to $4,500 per year to cover the cost of medications related to their treatment.
Uveitis is an inflammation of the uvea or the middle layer of the eye between the retina and the white of the eye. Uveitis is responsible for approximately 10 percent of the blindness in the United States. If the condition is diagnosed and treated promptly, a patient’s prognosis is good; however, left untreated, serious complications, including cataracts, glaucoma, and permanent vision loss, may result.
“Limited finances often keep people from being diagnosed and treated for uveitis in a timely manner,” said Julie Reynes, PAN President. “By providing financial assistance we hope uveitis patients can receive the medical attention they need.”
To qualify for assistance under this fund, patients must prove that they have health insurance, that their household income is under 400 percent of the Federal Poverty Level, and that they are being treated for uveitis. Patients can start the application process online at www.PANfoundation.org or by calling 1-866-316-PANF (7263).
This new fund is an expansion of PAN’s 28 existing cancer and chronic disease funds, which cover conditions such as rheumatoid arthritis, breast cancer, and colorectal cancer. PAN provides grants of $1,500-$10,000 per year to qualified patients to help pay for medications for these diseases. In 2009 PAN helped nearly 19,000 patients access their medications.
For more information on Patient Access Network, go to www.PANfoundation.org